(2E,6Z)-N-Ethylnona-2,6-dienamide
Common Name: |
(2E,6Z)-N-Ethylnona-2,6-dienamide |
IUPAC Name: |
(2E,6Z)-N-ethylnona-2,6-dienamide |
Molecular Formula: |
C16H26O |
SMILES: |
CCC=CCCC=CC(=O)NCC |
Inchi: |
1S/C11H19NO/c1-3-5-6-7-8-9-10-11(13)12-4-2/h5-6,9-10H,3-4,7-8H2,1-2H3,(H,12,13)/b6-5-,10-9+ |
Inchi Key: |
ARSJQOAYGVNWEK-MLCWLASSSA-N |
Cas No: |
608514-56-3 |
Name |
Value |
Lipinski Violations |
0 |
Ghose Violations |
0 |
Veber Violations |
0 |
Egan Violations |
0 |
Muegge Violations |
1 |
Name |
Value |
Molecular Weight (g/mol) |
234.38 |
Mass (g/mol) |
181.147 |
Molar Refractivity |
74.00 |
Net Charge |
|
HBD |
|
HBA |
1 |
Rt Bonds |
1 |
Rings |
|
TPSA |
17.07 |
Hetero Atoms |
2 |
Heavy Atoms |
17 |
Aromatic Heavy Atoms |
0 |
Melting Point (°C) |
|
Boiling Point (°C@760.00mm Hg) |
335.00 to 336.00 |
Vapor Pressure (mmHg@25.00 °C) |
0.00012 |
Vapor Density (Air =1) |
|
Fraction Csp3 |
0.81 |
LogP |
2.425 |
iLOGP |
2.98 |
XLOGP3 |
3.47 |
WLOGP |
4.52 |
MLOGP |
3.81 |
ESOL Log S |
-3.41 |
ESOL Solubility (mg/ml) |
0.091 |
ESOL Solubility (mol/l) |
0 |
ESOL Class: esol_class |
Soluble |
Ali Log S |
-3.51 |
Ali Solubility (mg/ml) |
0.07 |
Ali Solubility (mol/l) |
0 |
Ali Class |
Soluble |
Silicos-IT LogSw |
-4.26 |
Silicos-IT Solubility (mg/ml) |
0.01 |
Silicos-IT Solubility (mol/l) |
0 |
Silicos-IT Class |
Moderately soluble |
Name |
Value |
GI Absorption |
High |
BBB Permeable |
1 |
PgP Substrate |
0 |
Log Kp (cm/s) |
-5.27 |
Bioavailability Score |
0.55 |
Caco2 |
1 |
Human Intestinal Absorption |
1 |
Plasm Protein Binding |
0.405 |
CYP1A2 Inhibitor |
0 |
CYP2C19 Inhibitor |
1 |
CYP2C9 Inhibitor |
0 |
CYP2D6 inhibitor |
0 |
CYP3A4 inhibitor |
0 |
Ames mutagenesis |
0 |
Acute Oral Toxicity |
1.923 |
Carcinogenicity (Binary) |
0 |
Carcinogenicity (Trinary) |
Non-required |
Eye Irritation |
1 |
Hepatotoxicity |
0 |
Androgen Receptor Binding |
0 |
Aromatase Binding |
0 |
Estrogen Receptor Binding |
0 |
Glucocorticoid Receptor Binding |
0 |
Thyroid Receptor Binding |
0 |
BRCP inhibitor |
0 |
BSEP inhibitor |
0 |
OATP1B1 inhibitor |
1 |
OATP1B3 inhibitor |
1 |
OATP2B1 inhibitor |
0 |
OCT1 inhibitor |
0 |
OCT2 inhibitor |
0 |